Loading…
Chandan Healthcare (CHANDAN)₹240.00+2.13%Healthcare Service Provider
In the Jun 2026 quarter (consolidated), Chandan Healthcare reported sales of ₹80.80 Cr, up 19.0% from Jun 2025, and net profit of ₹7.96 Cr, up 28.2% year on year. For the year to Mar 2026, sales were ₹276 Cr and net profit ₹20.08 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 54.60 | 62.62 | 67.91 | 67.87 | 64.95 | 75.60 | 80.80 |
| Expenses | 45.68 | 52.37 | 54.00 | 53.74 | 53.13 | 64.05 | 61.25 |
| Operating Profit | 8.86 | 10.22 | 13.83 | 14.12 | 11.81 | 11.46 | 19.55 |
| OPM % | 16.2% | 16.3% | 20.4% | 20.8% | 18.2% | 15.2% | 24.2% |
| Other Income | 0.16 | 2.41 | 0.86 | 0.83 | −1.45 | 1.84 | 1.40 |
| Interest | 1.10 | 1.31 | 1.38 | 1.41 | 1.29 | 1.79 | 4.85 |
| Depreciation | 1.34 | 2.69 | 3.74 | 2.45 | 2.41 | 3.73 | 4.48 |
| Profit before tax | 6.63 | 8.67 | 9.63 | 11.16 | 6.71 | 7.82 | 11.72 |
| Tax % | 30.2% | 29.6% | 35.7% | 25.8% | 25.0% | 36.6% | 32.4% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | −1.52 | 0.00 | 0.00 |
| Net Profit | 4.22 | 6.04 | 6.21 | 7.83 | 4.56 | 4.96 | 7.96 |
| EPS (Rs) | 2.11 | 2.47 | 2.38 | 3.20 | 1.87 | 2.01 | 3.08 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| Sales | 120 | 137 | 177 | 230 | 276 | 289 |
| Expenses | 117 | 128 | 150 | 189 | 219 | 232 |
| Operating Profit | 1.99 | 8.98 | 25.94 | 40.93 | 56.90 | 56.94 |
| OPM % | 1.9% | 7.0% | 15.0% | 18.0% | 21.0% | 19.7% |
| Other Income | 0.00 | 0.00 | 0.99 | 1.99 | 3.99 | 2.62 |
| Interest | 2.01 | 2.01 | 3.01 | 5.02 | 14.04 | 9.34 |
| Depreciation | 1.99 | 1.99 | 2.99 | 6.99 | 14.99 | 13.07 |
| Profit before tax | −1.01 | 5.01 | 21.03 | 32.05 | 32.04 | 37.41 |
| Tax % | 3.0% | 28.0% | 24.0% | 27.0% | 37.0% | — |
| Net Profit | −1.01 | 3.01 | 16.06 | 24.09 | 20.08 | 25.31 |
| EPS (Rs) | −0.57 | 1.69 | 8.15 | 9.10 | 7.94 | 10.16 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 20.04 | 20.05 | 20.07 | 24.09 | 24.07 |
| Reserves | 4.01 | 7.01 | 21.05 | 98.26 | 147 |
| Borrowings | 16.93 | 20.95 | 35.99 | 48.05 | 53.96 |
| Other Liabilities | 41.18 | 49.23 | 41.19 | 40.19 | 65.31 |
| Total Liabilities | 82.16 | 98.24 | 118 | 212 | 291 |
| Fixed Assets | 29.10 | 33.10 | 48.19 | 76.27 | 101 |
| CWIP | 0.00 | 0.00 | 0.00 | 3.99 | 11.97 |
| Investments | 5.99 | 6.98 | 2.99 | 0.99 | 19.94 |
| Other Assets | 46.07 | 58.16 | 66.12 | 129 | 156 |
| Inventories | 7.01 | 10.02 | 18.03 | 32.04 | 34.04 |
| Trade receivables | 29.04 | 24.04 | 29.06 | 47.06 | 86.12 |
| Cash & equivalents | 2.01 | 2.01 | 4.01 | 6.02 | 4.01 |
| Total Assets | 82.16 | 98.24 | 118 | 212 | 291 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 6.01 | 4.01 | 0.99 | −29.01 | 16.01 |
| Cash from investing activity | −11.02 | −6.02 | −15.05 | −36.12 | −40.14 |
| Cash from financing activity | 3.01 | 2.01 | 16.05 | 67.20 | 21.07 |
| Net cash flow | −0.99 | 0.00 | 2.01 | 1.99 | −3.01 |
| Capex | 6.65 | 5.29 | 19.55 | 38.75 | 42.57 |
| Free cash flow | −0.99 | −0.99 | −17.98 | −67.94 | −25.98 |
| CFO / OP % | 275.0% | 60.0% | 23.0% | −50.0% | 45.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 89 | 64 | 60 | 75 | 115 |
| Inventory days | 47 | 72 | 97 | 127 | 93 |
| Days payable | 184 | 250 | 101 | 101 | 111 |
| Cash conversion cycle | −50 | −116 | 54 | 99 | 96 |
| Working capital days | −11 | −21 | −1 | 75 | 111 |
| ROCE % | — | 16.0% | 37.0% | 29.0% | 23.0% |
For the Jun 2026 quarter, Chandan Healthcare reported sales of ₹80.80 Cr, up 19.0% year on year and net profit of ₹7.96 Cr, up 28.2% year on year. The operating margin was 24.2%.
Chandan Healthcare's sales for the year to Mar 2026 were ₹276 Cr; over the last twelve months they were ₹289 Cr.
Net profit for the year to Mar 2026 was ₹20.08 Cr, and ₹25.31 Cr over the last twelve months. Earnings per share over the same trailing period were ₹10.16.
Chandan Healthcare reported borrowings of ₹53.96 Cr at Mar 2026, against cash and equivalents of ₹4.01 Cr.
Cash from operations was ₹16.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹25.98 Cr.